Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Zepbound (tirzepatide) is reshaping the competitive landscape in obesity treatment, challenging Novo Nordisk A/S' (NYSE:NVO) ...

Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

Can Ozempic and similar drugs cause muscle and bone loss? Discover how to maintain your health while achieving weight loss ...

The FDA is allowing pharmacies to dispense compounded versions of semaglutide and tirzepatide ... of the weight loss drugs — large amounts of people qualify for them and their high cost ...

As the New Year approaches, many of us feel refreshed and motivated to be our best. Whether you want to adopt a healthier lifestyle, set new fitness goals or just improve overall your well-being ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Tirzepatide is the active ingredient ... businesses will still be able to offer some lower-cost medications for weight loss since semaglutide, better known as Wegovy and Ozempic, is still ...